Glucosylsphingosine (Lyso-Gb(1)): An Informative Biomarker in the Clinical Monitoring of Patients with Gaucher Disease

Historically, disease burden and treatment responses in patients with Gaucher disease (GD) was assessed by monitoring clinical data, laboratory, imaging, chitotriosidase (CHITO), and other biomarkers; however, these biomarkers lack specificity and CHITO is uninformative in patients heterozygous or h...

Descripción completa

Detalles Bibliográficos
Autores principales: Gayed, Matthew M., Jung, Seung-Hye, Huggins, Erin, Rodriguez-Rassi, Eleanor, DeArmey, Stephanie, Kishnani, Priya Sunil, Stiles, Ashlee R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736277/
https://www.ncbi.nlm.nih.gov/pubmed/36499264
http://dx.doi.org/10.3390/ijms232314938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736277/
https://www.ncbi.nlm.nih.gov/pubmed/36499264
http://dx.doi.org/10.3390/ijms232314938

Ejemplares similares